GlassScriptPhysician profile
Alan Angell
NPI 1346234432
$1,132.76
in general payments reported to CMS, 2019-2025
24 companies · $95.31 in 2025
The $95.31 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.03 · 2020: $27.35 · 2021: $66.98 · 2022: $46.88 · 2023: $396 · 2024: $402 · 2025: $95.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $893.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $189.94 | 2024 | Myrisk |
| Urogen Pharma, INC. | $188.29 | 2020-2023 | Jelmyto |
| Axonics, INC. | $129.67 | 2024 | Axonics, Bulkamid |
| Antares Pharma, INC. | $122.81 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| 180 Medical, INC. | $99.22 | 2019-2025 | Gentlecath |
| Tolmar, INC. | $56.60 | 2023 | |
| Halozyme INC | $42.66 | 2023 | |
| Janssen Biotech, INC. | $33.03 | 2019-2022 | |
| Urovant Sciences INC | $27.03 | 2022 | |
| Boston Scientific Corporation | $21.96 | 2025 | Axonics |
| Sumitomo Pharma America, INC. | $20.58 | 2025 | Gemtesa |
| Laborie Medical Technologies Corp. | $20.31 | 2023 | |
| Ferring Pharmaceuticals INC. | $19.48 | 2019 | |
| Abbvie INC. | $18.73 | 2025 | |
| Allergan, INC. | $17.66 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.90 | 2025 | |
| Myovant Sciences INC. | $16.02 | 2021 | |
| Merck Sharp & Dohme LLC | $15.77 | 2024 | Welireg, Keytruda |
| Astellas Pharma US INC | $14.66 | 2023 | Xtandi |
| Medline Industries LP | $13.98 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.44 | 2019 | |
| Endo Pharmaceuticals INC. | $13.00 | 2023 | Xiaflex |
| Sagent Pharmaceuticals | $11.34 | 2021 | |
| Ambu INC. | $9.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Angell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.